• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Upstream Bio

News headline image
Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
March 12, 2025
From Upstream Bio
Via GlobeNewswire
Tickers UPB
News headline image
Upstream Bio Announces Appointment of Rand Sutherland as CEO and Additions to Leadership Team
April 02, 2024
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Initiates a Phase 2 Clinical Trial of Verekitug (UPB-101) in Severe Asthma and Doses First Patients
March 07, 2024
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces Dosing of First Patients in a Phase 2 Clinical Trial of Verekitug (UPB-101) in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
January 03, 2024
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces Positive Phase 1b Interim Data in Asthma and Company Progress Toward Phase 2
October 24, 2023
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
June 08, 2023
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Presents New Phase 1 Clinical Data on UPB-101 at the American Thoracic Society (ATS) International Conference
May 22, 2023
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio to Present New Clinical Data from Phase 1 Study of UPB-101 at the American Thoracic Society (ATS) International Conference
May 12, 2023
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces the Appointment of Marcella Ruddy, M.D., to the Board of Directors
February 07, 2023
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces Clinical Advisory and Leadership Appointments
October 06, 2022
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Announces Dosing of First Patient in a Phase 1b Clinical Trial of UPB-101 in Asthma
August 09, 2022
From Upstream Bio
Via Business Wire
News headline image
Upstream Bio Launches with $200M Series A Financing to Advance Novel Therapeutics for Allergic and Inflammatory Diseases
June 02, 2022
From Upstream Bio
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap